4//SEC Filing
Webb Michael J. 4
Accession 0001209191-12-027016
CIK 0001333170other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:36 PM ET
Size
13.0 KB
Accession
0001209191-12-027016
Insider Transaction Report
Form 4
Webb Michael J.
SVP, Quality & Regulatory
Transactions
- Exercise/Conversion
Common Stock
2012-05-07$2.11/sh+10,000$21,100→ 22,763 total - Exercise/Conversion
Common Stock
2012-05-07$4.54/sh+7,000$31,780→ 12,763 total - Sale
Common Stock
2012-05-07$16.76/sh−19,568$327,932→ 3,195 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-05-07−7,000→ 25,000 totalExercise: $4.54From: 2008-04-27Exp: 2015-03-26→ Common Stock (7,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2012-05-07−10,000→ 0 totalExercise: $2.11From: 2009-04-05Exp: 2016-03-04→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2012.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.53 to $16.95. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- [F3]This option was granted on March 27, 2008 and vests over four years in equal monthly installments.
- [F4]This option was granted on March 5, 2009 and vests over three years in equal monthly installments.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001409195
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 4:36 PM ET
- Size
- 13.0 KB